Inflammation and Cancer: Triggers, Mechanisms, and Consequences

被引:2450
作者
Greten, Florian R. [1 ,2 ,3 ,4 ]
Grivennikov, Sergei, I [5 ]
机构
[1] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Frankfurt Canc Inst, D-60596 Frankfurt, Germany
[3] German Canc Consortium DKTK, D-69120 Heidelberg, Germany
[4] German Canc Res Ctr, D-69120 Heidelberg, Germany
[5] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA
基金
美国国家卫生研究院;
关键词
TUMOR-ASSOCIATED MACROPHAGES; DELTA T-CELLS; NF-KAPPA-B; COLORECTAL-CANCER; BREAST-CANCER; IKK-BETA; INTESTINAL TUMORIGENESIS; PANCREATIC ONCOGENESIS; MAMMARY CARCINOMAS; ADAPTIVE IMMUNITY;
D O I
10.1016/j.immuni.2019.06.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 175 条
  • [71] Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism
    Johnson, Marc O.
    Wolf, Melissa M.
    Madden, Matthew Z.
    Andrejeva, Gabriela
    Sugiura, Ayaka
    Contreras, Diana C.
    Maseda, Damian
    Liberti, Maria V.
    Paz, Katelyn
    Kishton, Rigel J.
    Johnson, Matthew E.
    de Cubas, Aguirre A.
    Wu, Pingsheng
    Li, Gongbo
    Zhang, Yongliang
    Newcomb, Dawn C.
    Wells, Andrew D.
    Restifo, Nicholas P.
    Rathmell, W. Kimryn
    Locasale, Jason W.
    Davila, Marco L.
    Blazar, Bruce R.
    Rathmell, Jeffrey C.
    [J]. CELL, 2018, 175 (07) : 1780 - +
  • [72] Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma
    Kadariya, Yuwaraj
    Menges, Craig W.
    Talarchek, Jacqueline
    Cai, Kathy Q.
    Klein-Szanto, Andres J.
    Pietrofesa, Ralph A.
    Christofidou-Solomidou, Melpo
    Cheung, Mitchell
    Mossman, Brooke T.
    Shukla, Arti
    Testa, Joseph R.
    [J]. CANCER PREVENTION RESEARCH, 2016, 9 (05) : 406 - 414
  • [73] NFκB:: Linking inflammation and immunity to cancer development and progression
    Karin, M
    Greten, FR
    [J]. NATURE REVIEWS IMMUNOLOGY, 2005, 5 (10) : 749 - 759
  • [74] Mammary tumor-derived CCL2 enhances pro-metastatic systemic inflammation through upregulation of IL1β in tumor-associated macrophages
    Kersten, Kelly
    Coffelt, Seth B.
    Hoogstraat, Marlous
    Verstegen, Niels J. M.
    Vrijland, Kim
    Ciampricotti, Metamia
    Doornebal, Chris W.
    Hau, Cheei-Sing
    Wellenstein, Max D.
    Salvagno, Camilla
    Doshi, Parul
    Lips, Esther H.
    Wessels, Lodewyk F. A.
    de Visser, Karin E.
    [J]. ONCOIMMUNOLOGY, 2017, 6 (08):
  • [75] HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers (Publication with Expression of Concern. See vol. 129, pg. 2163, 2019)
    Khambu, Bilon
    Huda, Nazmul
    Chen, Xiaoyun
    Antoine, Daniel J.
    Li, Yong
    Dai, Guoli
    Koehler, Ulrike A.
    Zong, Wei-Xing
    Waguri, Satoshi
    Werner, Sabine
    Oury, Tim D.
    Gong, Zheng
    Yin, Xiao-Ming
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (06) : 2419 - 2435
  • [76] Adaptive immunity maintains occult cancer in an equilibrium state
    Koebel, Catherine M.
    Vermi, William
    Swann, Jeremy B.
    Zerafa, Nadeen
    Rodig, Scott J.
    Old, Lloyd J.
    Smyth, Mark J.
    Schreiber, Robert D.
    [J]. NATURE, 2007, 450 (7171) : 903 - U24
  • [77] Mesenchymal Cells in Colon Cancer
    Koliaraki, Vasiliki
    Pallangyo, Charles K.
    Greten, Florian R.
    Kollias, George
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : 964 - 979
  • [78] p53 is a suppressor of inflammatory response in mice
    Komarova, EA
    Krivokrysenko, V
    Wang, KH
    Neznanov, N
    Chernov, MV
    Komarov, PG
    Brennan, ML
    Golovkina, TV
    Rokhlin, O
    Kuprash, DV
    Nedospasov, SA
    Hazen, SR
    Feinstein, E
    Gudkov, AV
    [J]. FASEB JOURNAL, 2005, 19 (06) : 1030 - +
  • [79] Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
    Kortlever, Roderik M.
    Sodir, Nicole M.
    Wilson, Catherine H.
    Burkhart, Deborah L.
    Pellegrinet, Luca
    Swigart, Lamorna Brown
    Littlewood, Trevor D.
    Evan, Gerard I.
    [J]. CELL, 2017, 171 (06) : 1301 - +
  • [80] Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
    Kostic, Aleksandar D.
    Chun, Eunyoung
    Robertson, Lauren
    Glickman, Jonathan N.
    Gallini, Carey Ann
    Michaud, Monia
    Clancy, Thomas E.
    Chung, Daniel C.
    Lochhead, Paul
    Hold, Georgina L.
    El-Omar, Emad M.
    Brenner, Dean
    Fuchs, Charles S.
    Meyerson, Matthew
    Garrett, Wendy S.
    [J]. CELL HOST & MICROBE, 2013, 14 (02) : 207 - 215